Anaplastic large cell lymphoma, ALK-negative, spleen digital illustration

Anaplastic large cell lymphoma, ALK-negative, spleen Save


ICD-10 code: C84.77

Disease category: C84.7: Anaplastic large cell lymphoma, ALK-negative

Anaplastic Large Cell Lymphoma, ALK-Negative, Spleen

Anaplastic Large Cell Lymphoma (ALCL) is a rare type of non-Hodgkin lymphoma that primarily affects the lymph nodes. However, in some cases, it can also involve other organs, including the spleen. This article provides an overview of ALCL, focusing specifically on the ALK-negative subtype and its association with the spleen.

1. ALK-Negative ALCL:

ALK stands for anaplastic lymphoma kinase, a protein that plays a role in cell growth and division. In ALCL, there are two main subtypes: ALK-positive and ALK-negative. While ALK-positive ALCL is characterized by a specific genetic abnormality involving the ALK gene, ALK-negative ALCL lacks this genetic alteration.

2. Involvement of the Spleen:

The spleen is an organ located in the upper left part of the abdomen. It plays a crucial role in filtering the blood, removing old or damaged blood cells, and fighting infections. In some cases of ALCL, the disease can spread to the spleen, leading to spleen involvement.

3. Symptoms:

The symptoms of ALCL, including ALK-negative ALCL with spleen involvement, can vary from person to person. Common symptoms may include enlarged lymph nodes, fever, night sweats, fatigue, and weight loss. However, it's important to note that these symptoms can also be associated with other medical conditions.

4. Diagnostic Process:

To diagnose ALCL, various tests may be conducted, including physical examinations, blood tests, imaging scans, and biopsies. Biopsies involve removing a small piece of tissue from the affected area, such as a lymph node or the spleen, for further examination under a microscope.

5. Prognosis:

The prognosis for ALK-negative ALCL with spleen involvement can vary depending on several factors, including the stage of the disease, the patient's overall health, and the response to treatment. However, it's important to note that this article does not cover the treatment options for ALCL.

  1. In conclusion,
  2. ALK-negative ALCL is a rare subtype of non-Hodgkin lymphoma,
  3. and it can involve the spleen in some cases.
  4. Understanding the symptoms and diagnostic process is crucial for early detection and appropriate management.
  5. For specific treatment options and further information, it is important to consult with healthcare professionals.

Treatment of Anaplastic large cell lymphoma, ALK-negative, spleen:

Treatment Options for Anaplastic Large Cell Lymphoma, ALK-negative, Spleen

Anaplastic large cell lymphoma (ALCL) is a rare type of cancer that affects the lymphatic system. ALCL can be further categorized into ALK-positive and ALK-negative, depending on the presence or absence of a specific genetic mutation called anaplastic lymphoma kinase (ALK).

When ALCL affects the sple...

To see full information about treatment please Sign up or Log in